Call us today for help! 214-380-2134
A New Way to See What Scans Can’t For decades, CT scans and MRIs have been the standard tools for diagnosing mesothelioma. But a new discovery is shifting the landscape. A mesothelioma blood test is now showing signs of being able to detect cancer that imaging misses, and it may help doctors treat this aggressive …
Mesothelioma, a cancer linked to asbestos exposure, poses significant treatment challenges. Baylor College of Medicine (BCM) and Duke University are conducting a clinical trial to test a new treatment strategy, which could improve outcomes for patients. Mesothelioma is known for its aggressive progression, leading to a five-year survival rate of less than 10%. Though immunotherapy …
Rice University and Baylor College of Medicine researchers have achieved a groundbreaking experimental cancer treatment. Through a combination of Rice’s cytokine “drug factory” implants and a checkpoint inhibitor drug, advanced-stage mesothelioma tumors were completely eradicated in mice within a remarkably short period. This remarkable study, published in Clinical Cancer Research, showcases the immense potential of …
Three promising new mesothelioma treatments have recently been approved by the FDA or are in clinical trials. Approximately 2,500 Americans are diagnosed with mesothelioma each year. Mesothelioma is almost always caused by exposure to asbestos. Common exposures occurred in mines, construction, ships, industrial settings, refineries and chemical plants. Household exposures, hobbies and even home remodeling …
Johnson & Johnson, while not filing for bankruptcy protection itself, may still avoid asbestos talc liabilities. This is done by spinning liabilities off to a newly created subsidiary. Late last week, Johnson & Johnson (J&J) created a new subsidiary named LTL Management. Company officials confirmed the parent company then moved $2 billion in asbestos talc lawsuit …
